<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/2021.11.03.467186</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.11.03.467186v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;2021.11.03.467186</article-id><article-id pub-id-type="other" hwp:sub-type="slug">2021.11.03.467186</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">2021.11.03.467186</article-id><article-id pub-id-type="other" hwp:sub-type="tag">2021.11.03.467186</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Microbiology" hwp:journal="biorxiv"><subject>Microbiology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks <italic toggle="yes">in vitro</italic> replication of SARS-CoV-2 variants</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>#</label>Address correspondence to Christopher T. French, <email hwp:id="email-1">ctfrench@nau.edu</email></corresp><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2"><label>*</label><p hwp:id="p-1">These authors contributed equally to the study.</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Zarn Katherine E."><surname>Zarn</surname><given-names>Katherine E.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">a</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">*</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Jaramillo Sierra A."><surname>Jaramillo</surname><given-names>Sierra A.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">a</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">*</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Zapata Anthony R."><surname>Zapata</surname><given-names>Anthony R.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Stone Nathan E."><surname>Stone</surname><given-names>Nathan E.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Jones Ashley"><surname>Jones</surname><given-names>Ashley</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-5" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Nunnally Haley"><surname>Nunnally</surname><given-names>Haley</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-6" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Settles Erik W."><surname>Settles</surname><given-names>Erik W.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-7" hwp:rel-id="aff-1">a</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Ng Ken"><surname>Ng</surname><given-names>Ken</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-8" hwp:rel-id="aff-1">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Keim Paul"><surname>Keim</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-9" hwp:rel-id="aff-1">a</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Knudsen Steen"><surname>Knudsen</surname><given-names>Steen</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">c</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Nuijten Patricia"><surname>Nuijten</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">d</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Tijsma Aloys"><surname>Tijsma</surname><given-names>Aloys</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">d</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-13"><name name-style="western" hwp:sortable="French Christopher T."><surname>French</surname><given-names>Christopher T.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-10" hwp:rel-id="aff-1">a</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">b</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">#</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4 xref-aff-1-5 xref-aff-1-6 xref-aff-1-7 xref-aff-1-8 xref-aff-1-9 xref-aff-1-10"><label>a</label><institution hwp:id="institution-1">Pathogen and Microbiome Institute, Northern Arizona University</institution>, Flagstaff, AZ 86011-4073</aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3"><label>b</label><institution hwp:id="institution-2">Department of Biological Sciences, Northern Arizona University</institution>, Flagstaff, AZ 86011-5640</aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1"><label>c</label><institution hwp:id="institution-3">Allarity Therapeutics</institution>, DK-2970 Hørsholm, <country>Denmark</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2"><label>d</label><institution hwp:id="institution-4">Viroclinics-DDL</institution>, Rotterdam, <country>The Netherlands</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2021-11-05T14:03:12-07:00">
    <day>5</day><month>11</month><year>2021</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-11-05T14:03:12-07:00">
    <day>5</day><month>11</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2021-11-05T14:08:43-07:00">
    <day>5</day><month>11</month><year>2021</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-11-05T14:08:43-07:00">
    <day>5</day><month>11</month><year>2021</year>
  </pub-date><elocation-id>2021.11.03.467186</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2021-11-03"><day>03</day><month>11</month><year>2021</year></date>
<date date-type="rev-recd" hwp:start="2021-11-03"><day>03</day><month>11</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-11-05"><day>05</day><month>11</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license hwp:id="license-1"><p hwp:id="p-2">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="467186.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/2021.11.03.467186v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="467186.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/2021.11.03.467186v1/2021.11.03.467186v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/2021.11.03.467186v1/2021.11.03.467186v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-3">We recently published a preliminary assessment of the activity of a poly (ADP-ribose) polymerase (PARP) inhibitor, stenoparib, also known as 2X-121, which inhibits viral replication by affecting pathways of the host. Stenoparib is an inhibitor of mammalian poly (ADP-ribose) polymerases (PARPs). Here we show that stenoparib effectively inhibits additional SARS-CoV-2 variants, including an additional wild-type strain (Germany/BavPat1/2020), and the variants <italic toggle="yes">alpha</italic> (B.1.1.7), <italic toggle="yes">beta</italic> (B.1.351) and <italic toggle="yes">gamma</italic> (P.1) <italic toggle="yes">in vitro</italic>, with 50% effective concentration (EC<sub>50</sub>) estimates of 4.1 μM, 8.5 μM, 24.2 μM and 13.6 μM, respectively. A second study focusing on a combination of 10 μM stenoparib and 0.5 μM remdesivir resulted in over 90% inhibition of the <italic toggle="yes">alpha</italic> (B.1.1.7) variant, which is substantially greater than what was achieved with stenoparib or remdesivir alone at these concentrations.</p><sec hwp:id="sec-1"><title hwp:id="title-2">Importance</title><p hwp:id="p-4">The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has caused over 247 million infections and over 5 million deaths (<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>). Although protective vaccines are available, the pandemic continues and both old and new SARS-CoV-2 variants may exhibit degrees of resistance to vaccination. To date, only two antiviral drugs, remdesivir and molnupiravir, or treatment with monoclonal antibodies, have been approved by the United States Food and Drug Administration as COVID-19 therapies in certain situations. Additional effective therapeutics are urgently needed. Here we describe the activity of a small molecule, stenoparib, that effectively inhibits replication of SARS-CoV-2 wild-type and variant strains <italic toggle="yes">in vitro</italic>. Stenoparib is an inhibitor of mammalian poly (ADP-ribose) polymerases (PARPs). A host-targeting therapeutic like stenoparib could be a significant benefit for COVID-19 patients as a standalone therapy, or especially as part of a combinatorial COVID-19 treatment strategy with an antiviral drug such as remdesivir or molnupiravir.</p></sec></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-3">Keywords</title><kwd hwp:id="kwd-1">COVID-19</kwd><kwd hwp:id="kwd-2">antiviral</kwd><kwd hwp:id="kwd-3">SARS-CoV-2</kwd><kwd hwp:id="kwd-4">coronavirus</kwd><kwd hwp:id="kwd-5">stenoparib</kwd><kwd hwp:id="kwd-6">remdesivir</kwd></kwd-group><counts><page-count count="13"/></counts></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-4">Competing Interest Statement</title><p hwp:id="p-5">SK is employed by and holds a financial interest in Allarity Therapeutics, which stands to potentially benefit from these results.</p></notes></notes></front><body><sec id="s1" hwp:id="sec-2"><title hwp:id="title-5">Observation</title><p hwp:id="p-6">Since the beginning of the COVID-19 pandemic, SARS-CoV-2 has mutated, which has resulted in different variants of the virus. Only two antiviral drugs - remdesivir and molnupiravir, or treatment with monoclonal antibodies, have been approved by the United States Food and Drug Administration as COVID-19 therapies (<xref rid="c2" ref-type="bibr" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>, <xref rid="c3" ref-type="bibr" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>). Remdesivir and molnupiravir are nucleoside analogs that affect the activity of the RNA-dependent RNA polymerase (RdRp). After incorporation into viral RNA, remdesivir stalls the RdRp during elongation (<xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>), while molnupiravir results in the incorporation of mutations that can be functionally deleterious (<xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>). In contrast to inhibitors that target viral replication, we recently published a study on the activity of a poly (ADP-ribose) polymerase (PARP) inhibitor, stenoparib, also known as 2X-121, which inhibits viral replication by affecting pathways of the host (<xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>). ADP-ribosylation (ADPR) pathways may have either anti- or pro-viral properties, and their importance in host-virus interactions is becoming increasingly recognized (<xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>). Unlike remdesivir, which inhibits viral replication downstream of entry into the cell, stenoparib inhibits virus entry and post-entry processes (<xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-2" hwp:rel-id="ref-6">6</xref>). Stenoparib inhibited the SARS-CoV-2 USA-WA1/2020 virus and the HCoV-NL63 human seasonal respiratory coronavirus <italic toggle="yes">in vitro</italic>, exhibiting dose-dependent suppression of virus multiplication and cell-cell spread in cell culture (<xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-3" hwp:rel-id="ref-6">6</xref>). Stenoparib exhibits a unique dual activity against the PARP1, 2 and PARP5a, 5b (tankyrase 1, 2) enzymes, which are important intermediates in the Wnt/β-catenin immune checkpoint (<xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>, <xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>).</p><p hwp:id="p-7">SARS-CoV-2 variants may carry mutations throughout the genome, particularly in the sequence coding for the spike (S) protein. As a host-targeting therapeutic, we hypothesized that the antiviral activity of stenoparib should be able to inhibit all variant strains. We explored the activity of stenoparib against four additional SARS-CoV-2 variants of concern; SARS-CoV-2 Germany/BavPat1/2020 wild-type strain (wt) and variant strains (B.1.1.7 [<italic toggle="yes">alpha</italic>], B.1.351 [<italic toggle="yes">beta</italic>], and P1 [<italic toggle="yes">gamma</italic>] – hereafter referred to using the Greek nomenclature). SARS-CoV-2 virus variants were mixed with serial dilutions of compound and transferred to Vero E6 <italic toggle="yes">Cercopithecus aethiops</italic> kidney cells, which were fixed and stained 20 hours (h) later with a SARS-CoV/SARS-CoV-2 Nucleocapsid monoclonal antibody (Sino Biological) followed by a horseradish peroxidase (HRP)-labeled Goat anti-Mouse IgG (Thermo Scientific) and TrueBlue substrate. The 2 controls included on all assay plates were 1) infected and untreated cells and 2) uninfected and untreated cells. The experiment was conducted in quadruplicate and the results were calculated as the average fraction of wells that showed positive staining for the virus using ViroSpot assay (<xref rid="c10" ref-type="bibr" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>). Inhibition of virus replication by stenoparib was dose-dependent, with EC<sub>50</sub> ranging between 4.1 μM to 24.2 μM across the 4 variants tested (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig. 1A</xref>). Interestingly, the EC<sub>50</sub> for the <italic toggle="yes">beta</italic> variant (24.2 μM) was 1.8- to 5.8-fold higher than for the wt, <italic toggle="yes">alpha</italic>, and <italic toggle="yes">gamma</italic> variants (4.1, 8.5, and 13.6 μM, respectively). A similar phenomenon was noted for remdesivir (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig. 1B</xref>), where the EC<sub>50</sub> for the <italic toggle="yes">beta</italic> variant (9.9 μM) was 2.0- to 2.6-fold higher than for the wt, <italic toggle="yes">alpha</italic>, and <italic toggle="yes">gamma</italic> variants (3.8, 5.0, and 4.3 μM, respectively). According to a recent report, the <italic toggle="yes">beta</italic> variant appears to exhibit a significantly reduced eclipse period and more rapid replication <italic toggle="yes">in vitro</italic> (<xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>), which would likely affect its dose response toward stenoparib and remdesivir. The <italic toggle="yes">beta</italic> variant carries numerous changes to the S protein, several of which affect the receptor binding domain and are also common to the <italic toggle="yes">alpha</italic> and <italic toggle="yes">gamma</italic> variants. In addition to these changes, the <italic toggle="yes">beta</italic> variant carries mutations in the N protein and in the Nsp3 polyprotein (ORF1a), which may be involved in ADPR following infection (<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>). Differential susceptibility to ADPR may contribute to the altered replication kinetics of the <italic toggle="yes">beta</italic> variant, although this awaits experimental validation.</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.11.03.467186v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1.</label><caption hwp:id="caption-1"><p hwp:id="p-8">Dose-response curves for stenoparib and remdesivir on SARS-CoV-2 variants. <bold>A.</bold> stenoparib. <bold>B.</bold> remdesivir. Vero E6 cells (ATCC CRL-1586) were infected for 20 hours with SARS-CoV-2 wild type (wt) or the indicated variants in the presence or absence of stenoparib or remdesivir as indicated. Results are the average fraction of quadruplicate wells that exhibited positive staining for SARS-CoV-2 (y-axis) vs. the concentration of the inhibitors (x-axis). These data were used to estimate the EC<sub>50</sub> of stenoparib and remdesivir. The EC<sub>50</sub> values were approximated with the aid of the online calculator from AAT Bioquest (“Quest Graph™ EC<sub>50</sub> Calculator.” AAT Bioquest, Inc, 26 Oct. 2020, <ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.aatbio.com/tools/ec50-calculator" ext-link-type="uri" xlink:href="https://www.aatbio.com/tools/ec50-calculator" hwp:id="ext-link-1">https://www.aatbio.com/tools/ec50-calculator</ext-link>). Viruses; wild-type (wt): BetaCoV/Munich/BavPat1/2020, European Virus Archive Global. <italic toggle="yes">Alpha</italic>: USA/CA_CDC_5574/2020, BEI Resources, Cat# NR-54011. <italic toggle="yes">Beta</italic>: hCoV-19/South Africa/KRISP-K005325/2020, BEI Resources. <italic toggle="yes">Gamma</italic>: hCoV-19/Japan/TY7-503/2021 (Brazil P.1), BEI Resources.</p></caption><graphic xlink:href="467186v1_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-9">In an additional set of experiments, we focused on the SARS-CoV-2 <italic toggle="yes">alpha</italic> variant. Vero E6 cells were infected with the <italic toggle="yes">alpha</italic> variant using a multiplicity of infection of 0.1, and the activity of stenoparib was assessed using the plaque reduction assay. Plaques are areas of dead or destroyed cells and appear as small, clear regions in an infected cell monolayer after fixation and staining with crystal violet. Following infection and treatment with an inhibitor, cells were overlaid with low melting point agarose, fixed at 120 h post infection, stained with crystal violet, and plaques were manually counted. The 3 control types were 1) infected and untreated cells, 2) uninfected and untreated cells, and 3) infected cells treated with a combination of camostat mesylate and E64d (CE), which are protease inhibitors that prevent spike protein cleavage and virus entry into the cell (<xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>). For the analysis shown in <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig. 2A</xref> and <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">2B</xref>, we combined lower doses of stenoparib (2.5, 5.0, and 10 μM) with the previously reported 50% effective concentration (EC<sub>50</sub>) of remdesivir (0.5 μM) (<xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-4" hwp:rel-id="ref-6">6</xref>). In <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Fig. 2A</xref> and <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">2B</xref>, neither 10 μM stenoparib nor 0.5 μM remdesivir achieved greater than a 50% reduction in plaquing efficiency compared to the infected, untreated cells. When combined, however, synergy occurred as plaque inhibition increased to over 90% - superior to what was achievable with either drug alone (P &lt; 0.01) at these doses. Notably, this was accomplished without significant cytotoxicity (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Fig. 2C</xref>). Combinations of two or more drugs may lead to synergism through different mechanisms of action, which has the potential benefit of reducing individual doses of each drug and minimizing undesirable side effects.</p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.11.03.467186v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2.</label><caption hwp:id="caption-2"><p hwp:id="p-10">Activity of stenoparib and remdesivir on the <italic toggle="yes">alpha</italic> (B.1.1.7) variant. <bold>A.</bold> Virus Plaque assays. Vero E6 cells (ATCC CRL-1586) were infected for 2 hours with SARS-CoV-2 <italic toggle="yes">alpha</italic> (USA/CA_CDC_5574/2020, BEI Resources, Cat# NR-54011), washed, and overlaid with low-melting temp agarose/MEM with or without stenoparib and/or remdesivir at the concentrations indicated. The cell monolayers were fixed with 4% paraformaldehyde and stained with 0.1% crystal violet prior to manual counting of clear plaques. The experiment was performed using technical triplicates, and error bars represent the standard deviation of three independent experiments. Statistical analysis was performed using the Student’s unpaired t-test. * P &lt; 0.05, ** P &lt; 0.01 applies where indicated. <bold>B.</bold> Photographs of plate wells after crystal violet staining. Labels indicate the concentrations of stenoparib or remdesivir. Abbreviations: S = stenoparib, R = remdesivir at the concentrations indicated (e.g. S2.5 / R0.5 = stenoparib 2.5 μM, remdesivir 0.5 μM, etc.). <bold>C.</bold> Cytotoxicity measurements performed by the lactate dehydrogenase release assay (Promega Cytotox 96) 48 hours after infection. Inhibitors stenoparib or remdesivir were used at the indicated concentrations (x-axis). The assays were performed according to the manufacturer’s recommendations. Results from drug treatments were normalized to the fraction of maximum cytotoxicity (percent cytotoxicity; y-axis) achieved by detergent lysis of cells. The experiment was performed using technical triplicates, and error bars represent the standard deviation of three independent experiments.</p></caption><graphic xlink:href="467186v1_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-11">Besides the known roles for the PARP1 and PARP2 enzymes in DNA repair (<xref rid="c14" ref-type="bibr" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>, <xref rid="c15" ref-type="bibr" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>), members of the PARP family have numerous additional functions (<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>). The 18 known human PARPs appear to differentially affect viral replication; some exhibit proviral activity and others exhibit antiviral roles (<xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref>, <xref rid="c17" ref-type="bibr" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>–<xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>). In coronavirus, the N protein is mono (ADP) ribosylated (MARylated) during infection. Stability of the N protein is critical for viral genome replication, translation, packaging, and modulation of the host cell cycle (<xref rid="c22" ref-type="bibr" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>). The N protein is the only ADPR target definitively identified in coronavirus thus far (<xref rid="c17" ref-type="bibr" hwp:id="xref-ref-17-2" hwp:rel-id="ref-17">17</xref>), and the prevalence of this modification across multiple coronavirus families suggests an important role in virus stability (<xref rid="c17" ref-type="bibr" hwp:id="xref-ref-17-3" hwp:rel-id="ref-17">17</xref>). Despite this, the role of N protein MARylation, and of ADPR in general with regards to coronavirus stability, is not well characterized. Possibly ADPR has a role in regulating virus genome structure, similar to ADPR of histones or the adenovirus core proteins (<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>, <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref>). While remdesivir and molnupiravir inhibit the viral replicon, stenoparib likely acts through multiple targets. A combination of stenoparib and remdesivir or molnupiravir may be highly potent at inhibiting SARS-family coronaviruses including SARS-CoV-2.</p></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-6">Acknowledgements</title><p hwp:id="p-12">This research was supported by a grant from The Flinn Foundation, the Cowden Endowment for Microbiology, and an Arizona Board of Regents TRIF award. Core experiments were supported by service fees paid by Allarity Therapeutics.</p></ack><sec sec-type="COI-statement" hwp:id="sec-3"><title hwp:id="title-7">Conflict of Interest Statement</title><p hwp:id="p-13">SK is employed by and holds a financial interest in Allarity Therapeutics, which stands to potentially benefit from these results.</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-8">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1.</label><citation publication-type="website" citation-type="web" ref:id="2021.11.03.467186v1.1" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-1"><collab hwp:id="collab-1">WHO</collab>. <year>2021</year>. <ext-link l:rel="related" l:ref-type="uri" l:ref="https://covid19.who.int/" ext-link-type="uri" xlink:href="https://covid19.who.int/" hwp:id="ext-link-2">https://covid19.who.int/</ext-link>. Accessed <date-in-citation content-type="access-date">3 Nov 2021</date-in-citation>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2.</label><citation publication-type="website" citation-type="web" ref:id="2021.11.03.467186v1.2" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-2"><collab hwp:id="collab-2">Prevention USCfDCa</collab>. <year>2020</year>. <article-title hwp:id="article-title-2">Information for Clinicians on Investigational Therapeutics for Patients with COVID-19, <italic toggle="yes">on</italic> National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases</article-title>. <ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html" ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html" hwp:id="ext-link-3">https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html</ext-link>. Accessed <date-in-citation content-type="access-date">16 Oct 2021</date-in-citation>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Beigel JH"><surname>Beigel</surname> <given-names>JH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tomashek KM"><surname>Tomashek</surname> <given-names>KM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dodd LE"><surname>Dodd</surname> <given-names>LE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mehta AK"><surname>Mehta</surname> <given-names>AK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zingman BS"><surname>Zingman</surname> <given-names>BS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kalil AC"><surname>Kalil</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hohmann E"><surname>Hohmann</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chu HY"><surname>Chu</surname> <given-names>HY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Luetkemeyer A"><surname>Luetkemeyer</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kline S"><surname>Kline</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lopez de Castilla D"><surname>Lopez de Castilla</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Finberg RW"><surname>Finberg</surname> <given-names>RW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dierberg K"><surname>Dierberg</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tapson V"><surname>Tapson</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hsieh L"><surname>Hsieh</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patterson TF"><surname>Patterson</surname> <given-names>TF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Paredes R"><surname>Paredes</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sweeney DA"><surname>Sweeney</surname> <given-names>DA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Short WR"><surname>Short</surname> <given-names>WR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Touloumi G"><surname>Touloumi</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lye DC"><surname>Lye</surname> <given-names>DC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ohmagari N"><surname>Ohmagari</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Oh MD"><surname>Oh</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ruiz-Palacios GM"><surname>Ruiz-Palacios</surname> <given-names>GM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Benfield T"><surname>Benfield</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fatkenheuer G"><surname>Fatkenheuer</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kortepeter MG"><surname>Kortepeter</surname> <given-names>MG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Atmar RL"><surname>Atmar</surname> <given-names>RL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Creech CB"><surname>Creech</surname> <given-names>CB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lundgren J"><surname>Lundgren</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Babiker AG"><surname>Babiker</surname> <given-names>AG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pett S"><surname>Pett</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neaton JD"><surname>Neaton</surname> <given-names>JD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Burgess TH"><surname>Burgess</surname> <given-names>TH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bonnett T"><surname>Bonnett</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Green M"><surname>Green</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Makowski M"><surname>Makowski</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Osinusi A"><surname>Osinusi</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nayak S"><surname>Nayak</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lane HC"><surname>Lane</surname> <given-names>HC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Members A-SG"><surname>Members</surname> <given-names>A-SG</given-names></string-name>. <year>2020</year>. <article-title hwp:id="article-title-3">Remdesivir for the Treatment of Covid-19 - Final Report</article-title>. <source hwp:id="source-1">N Engl J Med</source> <volume>383</volume>:<fpage>1813</fpage>–<lpage>1826</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Kokic G"><surname>Kokic</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hillen HS"><surname>Hillen</surname> <given-names>HS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tegunov D"><surname>Tegunov</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dienemann C"><surname>Dienemann</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Seitz F"><surname>Seitz</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schmitzova J"><surname>Schmitzova</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Farnung L"><surname>Farnung</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Siewert A"><surname>Siewert</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hobartner C"><surname>Hobartner</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cramer P"><surname>Cramer</surname> <given-names>P</given-names></string-name>. <year>2021</year>. <article-title hwp:id="article-title-4">Mechanism of SARS-CoV-2 polymerase stalling by remdesivir</article-title>. <source hwp:id="source-2">Nat Commun</source> <volume>12</volume>:<fpage>279</fpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Kabinger F"><surname>Kabinger</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stiller C"><surname>Stiller</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schmitzova J"><surname>Schmitzova</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dienemann C"><surname>Dienemann</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kokic G"><surname>Kokic</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hillen HS"><surname>Hillen</surname> <given-names>HS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hobartner C"><surname>Hobartner</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cramer P"><surname>Cramer</surname> <given-names>P</given-names></string-name>. <year>2021</year>. <article-title hwp:id="article-title-5">Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis</article-title>. <source hwp:id="source-3">Nat Struct Mol Biol</source> <volume>28</volume>:<fpage>740</fpage>–<lpage>746</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1 xref-ref-6-2 xref-ref-6-3 xref-ref-6-4"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Stone NE"><surname>Stone</surname> <given-names>NE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jaramillo SA"><surname>Jaramillo</surname> <given-names>SA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jones AN"><surname>Jones</surname> <given-names>AN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vazquez AJ"><surname>Vazquez</surname> <given-names>AJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Martz M"><surname>Martz</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Versluis LM"><surname>Versluis</surname> <given-names>LM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raniere MO"><surname>Raniere</surname> <given-names>MO</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nunnally HE"><surname>Nunnally</surname> <given-names>HE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zarn KE"><surname>Zarn</surname> <given-names>KE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nottingham R"><surname>Nottingham</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ng KR"><surname>Ng</surname> <given-names>KR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sahl JW"><surname>Sahl</surname> <given-names>JW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wagner DM"><surname>Wagner</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Knudsen S"><surname>Knudsen</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Settles EW"><surname>Settles</surname> <given-names>EW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Keim P"><surname>Keim</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="French CT"><surname>French</surname> <given-names>CT</given-names></string-name>. <year>2021</year>. <article-title hwp:id="article-title-6">Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses <italic toggle="yes">In Vitro</italic></article-title>. <source hwp:id="source-4">mBio</source> <volume>12</volume>:<fpage>e03495</fpage>–<lpage>20</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Kuny CV"><surname>Kuny</surname> <given-names>CV</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sullivan CS"><surname>Sullivan</surname> <given-names>CS</given-names></string-name>. <year>2016</year>. <article-title hwp:id="article-title-7">Virus-Host Interactions and the ARTD/PARP Family of Enzymes</article-title>. <source hwp:id="source-5">PLoS Pathog</source> <volume>12</volume>:<fpage>e1005453</fpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="McGonigle S"><surname>McGonigle</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen Z"><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu J"><surname>Wu</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chang P"><surname>Chang</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kolber-Simonds D"><surname>Kolber-Simonds</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ackermann K"><surname>Ackermann</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Twine NC"><surname>Twine</surname> <given-names>NC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shie JL"><surname>Shie</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Miu JT"><surname>Miu</surname> <given-names>JT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huang KC"><surname>Huang</surname> <given-names>KC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moniz GA"><surname>Moniz</surname> <given-names>GA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nomoto K"><surname>Nomoto</surname> <given-names>K</given-names></string-name>. <year>2015</year>. <article-title hwp:id="article-title-8">E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling</article-title>. <source hwp:id="source-6">Oncotarget</source> <volume>6</volume>:<fpage>41307</fpage>–<lpage>23</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Thorsell AG"><surname>Thorsell</surname> <given-names>AG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ekblad T"><surname>Ekblad</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Karlberg T"><surname>Karlberg</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Low M"><surname>Low</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pinto AF"><surname>Pinto</surname> <given-names>AF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tresaugues L"><surname>Tresaugues</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moche M"><surname>Moche</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cohen MS"><surname>Cohen</surname> <given-names>MS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schuler H"><surname>Schuler</surname> <given-names>H</given-names></string-name>. <year>2017</year>. <article-title hwp:id="article-title-9">Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors</article-title>. <source hwp:id="source-7">J Med Chem</source> <volume>60</volume>:<fpage>1262</fpage>–<lpage>1271</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="van Baalen CA"><surname>van Baalen</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jeeninga RE"><surname>Jeeninga</surname> <given-names>RE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Penders GH"><surname>Penders</surname> <given-names>GH</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Gent B"><surname>van Gent</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Beek R"><surname>van Beek</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Koopmans MP"><surname>Koopmans</surname> <given-names>MP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rimmelzwaan GF"><surname>Rimmelzwaan</surname> <given-names>GF</given-names></string-name>. <year>2017</year>. <article-title hwp:id="article-title-10">ViroSpot microneutralization assay for antigenic characterization of human influenza viruses</article-title>. <source hwp:id="source-8">Vaccine</source> <volume>35</volume>:<fpage>46</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.11" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Pyke AT"><surname>Pyke</surname> <given-names>AT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nair N"><surname>Nair</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="van den Hurk AF"><surname>van den Hurk</surname> <given-names>AF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Burtonclay P"><surname>Burtonclay</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nguyen S"><surname>Nguyen</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barcelon J"><surname>Barcelon</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kistler C"><surname>Kistler</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schlebusch S"><surname>Schlebusch</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="McMahon J"><surname>McMahon</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moore F"><surname>Moore</surname> <given-names>F</given-names></string-name>. <year>2021</year>. <article-title hwp:id="article-title-11">Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene</article-title>. <source hwp:id="source-9">Viruses</source> <volume>13</volume>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Lei J"><surname>Lei</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kusov Y"><surname>Kusov</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hilgenfeld R"><surname>Hilgenfeld</surname> <given-names>R</given-names></string-name>. <year>2018</year>. <article-title hwp:id="article-title-12">Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein</article-title>. <source hwp:id="source-10">Antiviral Res</source> <volume>149</volume>:<fpage>58</fpage>–<lpage>74</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Hoffmann M"><surname>Hoffmann</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kleine-Weber H"><surname>Kleine-Weber</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schroeder S"><surname>Schroeder</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kruger N"><surname>Kruger</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Herrler T"><surname>Herrler</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Erichsen S"><surname>Erichsen</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schiergens TS"><surname>Schiergens</surname> <given-names>TS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Herrler G"><surname>Herrler</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu NH"><surname>Wu</surname> <given-names>NH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nitsche A"><surname>Nitsche</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Muller MA"><surname>Muller</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Drosten C"><surname>Drosten</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pohlmann S"><surname>Pohlmann</surname> <given-names>S</given-names></string-name>. <year>2020</year>. <article-title hwp:id="article-title-13">SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</article-title>. <source hwp:id="source-11">Cell</source> <volume>181</volume>:<fpage>271</fpage>–<lpage>280 e8</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Dziadkowiec KN"><surname>Dziadkowiec</surname> <given-names>KN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gasiorowska E"><surname>Gasiorowska</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nowak-Markwitz E"><surname>Nowak-Markwitz</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jankowska A"><surname>Jankowska</surname> <given-names>A</given-names></string-name>. <year>2016</year>. <article-title hwp:id="article-title-14">PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting</article-title>. <source hwp:id="source-12">Prz Menopauzalny</source> <volume>15</volume>:<fpage>215</fpage>–<lpage>219</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Ame JC"><surname>Ame</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rolli V"><surname>Rolli</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schreiber V"><surname>Schreiber</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Niedergang C"><surname>Niedergang</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Apiou F"><surname>Apiou</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Decker P"><surname>Decker</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Muller S"><surname>Muller</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hoger T"><surname>Hoger</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Menissier-de Murcia J"><surname>Menissier-de Murcia</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Murcia G"><surname>de Murcia</surname> <given-names>G</given-names></string-name>. <year>1999</year>. <article-title hwp:id="article-title-15">PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase</article-title>. <source hwp:id="source-13">J Biol Chem</source> <volume>274</volume>:<fpage>17860</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Gupte R"><surname>Gupte</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu Z"><surname>Liu</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kraus WL"><surname>Kraus</surname> <given-names>WL</given-names></string-name>. <year>2017</year>. <article-title hwp:id="article-title-16">PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes</article-title>. <source hwp:id="source-14">Genes &amp; development</source> <volume>31</volume>:<fpage>101</fpage>–<lpage>126</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1 xref-ref-17-2 xref-ref-17-3"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Grunewald ME"><surname>Grunewald</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fehr AR"><surname>Fehr</surname> <given-names>AR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Athmer J"><surname>Athmer</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Perlman S"><surname>Perlman</surname> <given-names>S</given-names></string-name>. <year>2018</year>. <article-title hwp:id="article-title-17">The coronavirus nucleocapsid protein is ADP-ribosylated</article-title>. <source hwp:id="source-15">Virology</source> <volume>517</volume>:<fpage>62</fpage>–<lpage>68</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Grunewald ME"><surname>Grunewald</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen Y"><surname>Chen</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kuny C"><surname>Kuny</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maejima T"><surname>Maejima</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lease R"><surname>Lease</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferraris D"><surname>Ferraris</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aikawa M"><surname>Aikawa</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sullivan CS"><surname>Sullivan</surname> <given-names>CS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Perlman S"><surname>Perlman</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fehr AR"><surname>Fehr</surname> <given-names>AR</given-names></string-name>. <year>2019</year>. <article-title hwp:id="article-title-18">The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression</article-title>. <source hwp:id="source-16">PLoS Pathog</source> <volume>15</volume>:<fpage>e1007756</fpage>.</citation></ref><ref id="c19" hwp:id="ref-19"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Li L"><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhao H"><surname>Zhao</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu P"><surname>Liu</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li C"><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Quanquin N"><surname>Quanquin</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ji X"><surname>Ji</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sun N"><surname>Sun</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Du P"><surname>Du</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Qin C-F"><surname>Qin</surname> <given-names>C-F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lu N"><surname>Lu</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cheng G"><surname>Cheng</surname> <given-names>G</given-names></string-name>. <year>2018</year>. <article-title hwp:id="article-title-19">PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins</article-title>. <source hwp:id="source-17">Science signaling</source> <volume>11</volume>:<fpage>eaas9332</fpage>.</citation></ref><ref id="c20" hwp:id="ref-20"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Atasheva S"><surname>Atasheva</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frolova EI"><surname>Frolova</surname> <given-names>EI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frolov I"><surname>Frolov</surname> <given-names>I</given-names></string-name>. <year>2014</year>. <article-title hwp:id="article-title-20">Interferon-stimulated poly(ADP-Ribose) polymerases are potent inhibitors of cellular translation and virus replication</article-title>. <source hwp:id="source-18">Journal of virology</source> <volume>88</volume>:<fpage>2116</fpage>–<lpage>2130</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Westera L"><surname>Westera</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jennings AM"><surname>Jennings</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maamary J"><surname>Maamary</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schwemmle M"><surname>Schwemmle</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Garcia-Sastre A"><surname>Garcia-Sastre</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bortz E"><surname>Bortz</surname> <given-names>E</given-names></string-name>. <year>2019</year>. <article-title hwp:id="article-title-21">Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase</article-title>. <source hwp:id="source-19">Adv Virol</source> <volume>2019</volume>:<fpage>8512363</fpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="McBride R"><surname>McBride</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Zyl M"><surname>van Zyl</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fielding BC"><surname>Fielding</surname> <given-names>BC</given-names></string-name>. <year>2014</year>. <article-title hwp:id="article-title-22">The coronavirus nucleocapsid is a multifunctional protein</article-title>. <source hwp:id="source-20">Viruses</source> <volume>6</volume>:<fpage>2991</fpage>–<lpage>3018</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Déry CV"><surname>Déry</surname> <given-names>CV</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Murcia G"><surname>de Murcia</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lamarre D"><surname>Lamarre</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morin N"><surname>Morin</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Poirier GG"><surname>Poirier</surname> <given-names>GG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weber J"><surname>Weber</surname> <given-names>J</given-names></string-name>. <year>1986</year>. <article-title hwp:id="article-title-23">Possible role of ADP-ribosylation of adenovirus core proteins in virus infection</article-title>. <source hwp:id="source-21">Virus Research</source> <volume>4</volume>:<fpage>313</fpage>–<lpage>329</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.11.03.467186v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Strickfaden H"><surname>Strickfaden</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="McDonald D"><surname>McDonald</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kruhlak MJ"><surname>Kruhlak</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Haince J-F"><surname>Haince</surname> <given-names>J-F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Th'ng JPH"><surname>Th'ng</surname> <given-names>JPH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rouleau M"><surname>Rouleau</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ishibashi T"><surname>Ishibashi</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Corry GN"><surname>Corry</surname> <given-names>GN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ausio J"><surname>Ausio</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Underhill DA"><surname>Underhill</surname> <given-names>DA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Poirier GG"><surname>Poirier</surname> <given-names>GG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hendzel MJ"><surname>Hendzel</surname> <given-names>MJ</given-names></string-name>. <year>2016</year>. <article-title hwp:id="article-title-24">Poly(ADP-ribosyl)ation-dependent Transient Chromatin Decondensation and Histone Displacement following Laser Microirradiation*</article-title>. <source hwp:id="source-22">Journal of Biological Chemistry</source> <volume>291</volume>:<fpage>1789</fpage>–<lpage>1802</lpage>.</citation></ref></ref-list></back></article>
